TGIR Randomized Placebo-controlled Healthy Subject Study

Phase 4 Unknown 24 enrolled University of British Columbia Resilience Biosciences Inc (RBI) · collab

RandomizedCrossoverSingle-blindOther

Summary

The primary research objective of this study is to confirm the absence of side-effects and explore any analgesic properties of the botanical formulation TGIR (Traditional Gastrointestinal Remedy) in healthy participants.

Timeline

Start: 2022-11-01
Primary completion: 2023-12
Completion: 2023-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Traditional Gastrointestinal Remedy	Unknown	1 g	—

Indications

No indication recorded.